Authors of a 2012 article in Infection and Immunity investigating a malaria vaccine strategy are retracting it because it “contains several images that do not accurately reflect the experimental data.”
The retraction notice places the blame for the image shenanigans squarely on the first author, Asim Siddiqui, who is currently listed on LinkedIn as a faculty member at the College of Applied Medicine at King Saud University in Saudi Arabia.
Both retractions appeared in Biochemical and Biophysical Research Communications, one in October 2014 and one in January 2015. His story began two decades ago in 1994, when he published a paper in Nature that couldn’t be reproduced, and was eventually retracted in 2013.
Nearly two decades after a Polish researcher plagiarized the work of a Turkish team, her theft has been exposed and the paper retracted.
According to an article in Polish-language paper Gazeta Wyborcza, Jolanta Rzymowska of the Medical University of Lublin was the subject of two disciplinary hearings, the first in February 2014, following the discovery of her plagiarism by well-known Polish fraud hunter Marek Wronski. It was determined that her 1996 paper contained word-for-word text from a paper by a team at the University of Ankara.
We’ve found a third retraction for Karel Bezouška, the Czech scientist, who, as we reported this summer, broke into a lab in an attempt to tamper with experiments trying to replicate his own falsified data.
The article, “Molecular Characterization of Binding of Calcium and Carbohydrates by an Early Activation Antigen of Lymphocytes CD69,” had appeared in 2003 in Biochemistry. and has been cited 29 times, according to Thomson Scientific’s Web of Knowledge.
In August, we reported on a case in which a researcher had been fired from Leiden University in the Netherlands for fraud. The university said there would be two retractions, but did not name the researcher in question. At the same time, however, there were clues in the university’s report that suggested it could only be one person, the lead author of a 2010 study in the Proceedings of the National Academy of Sciences (PNAS) that was to be retracted.
A group of Belgian researchers has retracted two decade-old papers in Arthritis & Rheumatism following an investigation and court case.
The papers involved the use of the drug infliximab — sold by Johnson & Johnson as Remicade — to treat Sjögren’s syndrome, an auto-immune condition marked by the destruction of exocrine glands that secrete saliva and tears.
Infliximab is not approved for Sjögren’s. Although the two now-retracted studies suggested that it might be helpful, subsequent data did not support those findings.
In late December, we reported on the retraction of a 2010 research letter in Emerging Infectious Diseases looking at the genetics of swine flu.
The notice in the journal, a CDC publication, indicated that the conclusions were in error, although it didn’t really say much more:
To the Editor: We would like to retract the letter entitled “Triple Reassortant Swine Influenza A (H3N2) Virus in Waterfowl,” which was published the April 2010 issue of Emerging Infectious Diseases (1). The nucleoprotein gene sequences from the viruses reported in that letter are very closely related to those from the earliest detected triple reassortant swine influenza viruses [CY095676 A/sw/Texas/4199–2/1998(H3N2)]. Although these viruses could have acquired a swine-origin segment, the branch lengths are quite short for 9 years of evolution. Therefore, we have withdrawn these 4 isolates from GenBank and subsequently retract this letter.